# CT 327 in the "Atopy Patch Test" Model

> **NCT01368315** · PHASE1 · WITHDRAWN · sponsor: **Creabilis SA** · enrollment: 20 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** CT327 application
- **DRUG:** Placebo
- **DRUG:** Active comparator
- **DRUG:** No intervention

## Key facts

- **NCT ID:** NCT01368315
- **Lead sponsor:** Creabilis SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Why stopped:** Strategic decision
- **Last updated:** 2011-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01368315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01368315, "CT 327 in the "Atopy Patch Test" Model". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01368315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*